| Compound-Induced Block of Ion Channel Pore Function: Inward-Rectifier Potassium Channels as a Model |
Abstract PDF |
| Kazuharu Furutani, Hiroshi Hibino, Atsushi Inanobe, Yoshihisa Kurachi |
234-244 |
| Endothelin-1, an Endogenous Irreversible Agonist in Search of an Allosteric Inhibitor |
Abstract PDF |
| Jo G.R. De Mey, Matthijs G. Compeer, Merlijn J. Meens |
246-257 |
| Estrogen’s Place in the Family of Synaptic Modulators |
Abstract PDF |
| Enikö A. Kramár, Lulu Y. Chen, Christopher S. Rex, Christine M. Gall, Gary Lynch |
258-262 |
| A Potential Preclinical Migraine Model: CGRP-Sensitized Mice |
Abstract PDF |
| Andrew F. Russo, Adisa Kuburas, Eric A. Kaiser, Ann C. Raddant, Ana Recober |
264-270 |
| Integrins and Oncogenes: Partners in Crime |
Abstract PDF |
| Jordi Carreras Puigvert, Louise von Stechow, Bob van de Water, Erik HJ Danen |
272-277 |
| The Role of PTHrP in Mitogenic Signaling via EGFR-Dependent Pathways in Breast Cancer Cells |
Abstract PDF |
| Majed S. Alokail |
278-289 |
| The Role of Gadd45a in Suppression of Autoimmunity |
Abstract PDF |
| Heiko Johnen, Jesús M. Salvador |
290-298 |
| FDA Approves Kalbitor for Treating Potentially Life-Threatening Attacks of Hereditary Angioedema |
Abstract PDF |
| |
300 |
| FDA Approves Lysteda to Treat Heavy Menstrual Bleeding |
Abstract PDF |
| |
300 |
| FDA Approves New Treatment for Chronic Lymphocytic Leukemia |
Abstract PDF |
| |
301 |
